These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8630724)

  • 1. Terfenadine, astemizole, and ebastine produce QTc interval prolongation in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Egan RW; Kreutner W
    Ann Allergy Asthma Immunol; 1996 May; 76(5):476. PubMed ID: 8630724
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
    Hey JA; del Prado M; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
    Delgado LF; Pferferman A; Solé D; Naspitz CK
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval.
    Gillen MS; Miller B; Chaikin P; Morganroth J
    Br J Clin Pharmacol; 2001 Aug; 52(2):201-4. PubMed ID: 11488779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity of second-generation antihistamines.
    Roberts DJ
    Drugs; 1999 Jun; 57(6):1033-4. PubMed ID: 10400411
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of second generation histamine antagonists on the heart].
    Grzelewska-Rzymowska I; Pietrzkowicz M; Górska M
    Pneumonol Alergol Pol; 2001; 69(3-4):217-26. PubMed ID: 11575008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac effects of ebastine and other antihistamines in humans.
    Moss AJ; Morganroth J
    Drug Saf; 1999; 21 Suppl 1():69-80; discussion 81-7. PubMed ID: 10597870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
    Malik M
    J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity of new antihistamines and cisapride.
    Paakkari I
    Toxicol Lett; 2002 Feb; 127(1-3):279-84. PubMed ID: 12052668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR; Faulds D
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urticaria due to antihistamines.
    Sánchez Morillas L; Rojas Pérez-Ezquerra P; Reaño Martos M; Sanz ML; Laguna Martínez JJ
    J Investig Allergol Clin Immunol; 2011; 21(1):66-8. PubMed ID: 21370726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions associated with terfenadine and related nonsedating antihistamines.
    Zechnich AD; Haxby DG
    West J Med; 1996 Jan; 164(1):68-9. PubMed ID: 8779212
    [No Abstract]   [Full Text] [Related]  

  • 14. H1-receptor antagonists: safety issues.
    Estelle F; Simons R
    Ann Allergy Asthma Immunol; 1999 Nov; 83(5):481-8. PubMed ID: 10582735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the cardiac systemic side-effects of antihistamines: ebastine.
    Moss AJ; Chaikin P; Garcia JD; Gillen M; Roberts DJ; Morganroth J
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():200-5. PubMed ID: 10444238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of terfenadine, astemizole and epinastine on electrocardiogram in conscious cynomolgus monkeys.
    Ohmura T; Chachin M; Tarui S; Nagakura A; Igarashi T; Ikeda H; Ikegami K; Kitagawa H; Uchida S
    Eur J Pharmacol; 1999 Aug; 378(2):169-75. PubMed ID: 10478629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical in vitro cardiac electrophysiology: a method of predicting arrhythmogenic potential of antihistamines in humans?
    Cavero I; Mestre M; Guillon JM; Heuillet E; Roach AG
    Drug Saf; 1999; 21 Suppl 1():19-31; discussion 81-7. PubMed ID: 10597865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-generation antihistamines: the risk of ventricular arrhythmias.
    DuBuske LM
    Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihistamines. How safe are they?].
    MMW Fortschr Med; 2002 Sep; 144(37):53. PubMed ID: 12380340
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of ketoconazole in the QTc interval prolonging effects of H1-antihistamines in a guinea-pig model of arrhythmogenicity.
    Gras J; Llenas J; Palacios JM; Roberts DJ
    Br J Pharmacol; 1996 Sep; 119(2):187-8. PubMed ID: 8886395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.